Trading

Data

Solutions

Insights

Benchling Stock

benchling.comHealthcareFounded: 2012Funding to Date: $424.97MM

Benchling is a biotechnology company and developer of a platform that allows researchers to design and run experiments, analyze data, and share results.

Buy or sell Benchling stock Learn more about Benchling IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

View Enterprise Value for Benchling.

Register Today

Team

Management Team

Ashutosh Singhal

Co-Founder and Board Member

Kaiser Mulla-Feroze

Chief Marketing Officer

Sherwin Yu

Engineering Manager

Sajith Wickramasekara

Co-Founder, Chief Executive Officer and Board Member

Board Members

Eric Vishria

Sajith Wickramasekara

Balaji Srinivasan Ph.D

Andreessen Horowitz

Miles Grimshaw

Thrive Capital

Ashutosh Singhal

Other companies like Benchling in the Healthcare sector

Neuralink

Sector

Healthcare

Last Round Est. Valuation

$2.15B

Sector

Sector

Last Round Est. Valuation

$3.67B

Synchron

Sector

Healthcare

Last Round Est. Valuation

$400.53MM

Grail

Sector

Healthcare

Last Round Est. Valuation

$4.26B

Sector

Sector

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Healthcare

News

TechInsider 01/27/2021

$900 million cloud startup Benchling just launched a new product to help companies ramp up COVID research

Benchling, which is backed by investors Andreessen Horowitz and Thrive Capital, is helping customers scale coronavirus research and testing.

Crunchbase 06/01/2020

Benchling Brings In $50M Series D To Advance Biotech R&D

Benchling's cloud-based R&D platform helps scientists make breakthrough discoveries faster.

FINSMES 05/29/2020

Benchling Raises $50M in Series D Funding | FinSMEs

Benchling, a San Francisco, CA-based life sciences R&D cloud platform, closed $50m in Series D funding

Popular Topics

Popular Topics

Benchling Stock

Register for Details